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Abstract
Context and Objective: Prostate cancer is a major public health issue. Its incidence is rising, especially in Nigeria. Prompt 
diagnosis is necessary by histology. Transperineal and transrectal approaches to prostate biopsy are well-documented. 
Both methods are fraught with complications though, most times minor. Studies carried out to compare both methods 
were carried out mainly on Caucasians, generating conflicting results. This study aims to compare the complication 
rates and tissue yield of these two methods in Nigerian men.
Materials and Methods: Seventy-five patients completed the study. Forty-five patients had transperineal prostate 
biopsy (TPbx), while 30 patients had transrectal prostate biopsy. Pain perception for all patients was determined by 
visual analog scale; whereas the complications were ascertained by a validated purpose designed questionnaire 
administered on the 7th and 30th day post operatively.
Results: The risk of rectal bleeding was higher for transrectal prostate biopsy compared to transperineal 
(Odds ratio: 0.03; 95% confidence interval (CI): 0.001–0.450; P = 0.012). TPbx was more painful than 
transrectal (P < 0.0001; df: 75; t: 4.98; 95%CI of difference in mean: −2.98−[−1.28]). There was no statistical difference 
between transperineal and transrectal prostate biopsy in hemospermia, fever, prostatic abscess, urethral bleeding, 
acute retention and tissue yield.
Conclusion: TPbx is more painful than transrectal prostate biopsy though with a significantly reduced risk of rectal 
bleeding. There appears to be no significant difference with respect to risk of fever, urethral bleeding, hematospermia, 
prostatic abscess and acute retention. Both routes provided sufficient prostate tissue for histology.
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Introduction
Prostate cancer (PC) constitute a major public health 
issue[1,2] accounting for a greater percentage of the 
neoplastic lesion in men.[3] The incidence of PC is on 
the rise[4,5] necessitating the need to screen. Serum 
prostate specific antigen (PSA) has been widely adopted 
for screening, with the aim of detecting early disease. 
Following elevated PSA, a histological diagnosis is 
required in order to guide treatment. Over the years, 
different methods were adopted to biopsy the prostate 
for histology.
Initially, it was by digital guided prostate biopsy[6] which may 
be transperineal or transrectal. Later, this was replaced by 
ultrasound guided prostate biopsy. Recently, the extended 
approaches through either ultrasound guided transrectal or 
transperineal routes have been adopted.[7]
In most developing countries, patients tend to present late.[8] 
Most times, on presentation digital rectal examination (DRE) 
is already abnormal with elevated PSA. Unfortunately, in 
most centers in these resource poor settings, there is a paucity 
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of transrectal ultrasound (TRUS) to guide prostate biopsy 
and urologists still rely on digital guidance for prostate 
biopsy. Though, this may be argued to occasionally miss 
the lesions, some studies have demonstrated no significant 
difference between TRUS guidance and digital guidance to 
direct systematic biopsies of the prostate, especially if there 
are obvious lesions on DREs.[9,10] They concluded that 
the value of routine TRUS in screening program in such 
situations is doubtful.
However, for patients with elevated PSA but have normal 
DRE findings, such individuals are usually referred to the 
few centers with TRUS so as to have their repeat biopsies 
if the digital guided biopsy is negative.
Transrectal prostate biopsy is the commonest procedure for 
PC detection. Transperineal prostate biopsy (TPbx) is rarely 
used.[11] Interestingly, only few institutions still perform 
transperineal prostate biopsy,[12,13] though a prospective 
study has proven its superiority over transrectal prostate 
biopsy in cancer detection.[14] There are different reasons 
in support of transrectal prostate biopsy against transrectal. 
These arguments bothered on rate of complications, 
comfort of the patient and tissue yield. Few studies[15] have 
compared transrectal, and transperineal prostate biopsies, 
and these were done mainly on Caucasians. As such there is 
a knowledge gap in African blacks on the best approach to 
prostate biopsy. This study aims to fill this gap by comparing 
rate of complications, tissue yield and procedure related pain 
of transperineal with transrectal biopsy.
Materials and Methods
This study was carried out by the urology division of Enugu 
State University Teaching Hospital, which is located in 
Enugu, Nigeria. A total of 100 patients who presented to the 
urology clinic was enrolled into this study between January 
and December 2011.
The sample size was calculated using a statistical formula 
shown below:





Where N = Minimum sample size for a comparative study 
design.
Z = The standard normal deviation corresponding to 95% 
level of significance. The value obtained from a normal 
distribution table is 1.96.
P = Prevalence rate obtained from Ezenwa et al. study[5] 
=13.3% =0.133.
Q = (1–P)
δ  = Absolute precision that is,  value required 
(in percentage points) which in actual term describes the 
maximum difference between the population rate and the 
sample rate that can be tolerated; taken for this study to 
be 10% (0.1).
DEFF = Estimated design effect = 1
N =
× × × =1 96 133 867 1  44
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One hundred patients were randomly allocated to two 
groups. Once a patient met the indication for biopsy, he was 
assigned to a particular group based on a “lucky dip.” The 
two groups (A and B) were wrapped differently in pieces 
of paper and placed in an envelop; each envelop has ten 
equal wraps of group A and B. The patient dips and picks, 
whatever group picked, the patient gets assigned to it. 
The selected wrap is replaced before another patient does 
his lucky dip. The Inclusion criteria were: Patients with 
PSA greater than 4 ng/ml or abnormal DRE findings. The 
exclusion criteria were: Patients who were uraemic or had 
uncontrolled hypertension or bleeding diathesis or patients 
on anticoagulants or antiplatelets medications.
A detailed history was taken from all participants to identify 
any predilection for bleeding or any history of being on 
anticoagulant medications (i.e. warfarin, or heparin) or 
antiplatelet drugs like aspirin. In the period of the study, no 
patient presented with ecchymosis that is commoner among 
hemophiliacs. All the patients had routine investigations 
which included full blood count, serum urea, and creatinine 
and clotting profile for all patients with a history of 
anticoagulant or antiplatelet medications.
Twenty‑five patients were lost to follow up. Twenty patients 
never showed up on the 30th day post operative, while five 
patients presented 3 months after biopsy on account of 
financial constraint. Seventy‑five patients completed the 
study. The study was approved by Enugu State University 
Teaching Hospital Ethical committee. Informed consent was 
obtained from all patients recruited for the study.
These procedures were done by two urologists who have 
seven years urological experience. Prior to the biopsy 
the patients were educated on the use of visual analog 
scale (VAS) to ascertain their level of pain following biopsy.
The VAS is a psychometric response scale which in this 
study, respondents had to specify their level of agreement 
to a statement by indicating a position along a continuous 
line between two end‑points (0 and 10). The zero end 
points signify no discomfort while the ten end points signify 
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most‑severe pains. There is evidence showing that VAS 
have superior metrical characteristics than discrete scales, 
thus a wider range of statistical methods can be applied to 
the measurements.[17]
The respondents were also educated on the possible 
symptoms that may arise as complications from the biopsy 
procedure.
Procedure
The position adopted for biopsy in this study was lithotomy. 
Intravenous (IV) ciprofoxacin 200 mg, IV metronidazole 
400 mg.[18] and IV (pentazocine 30 mg) were given to 
patients in both groups (A and B). The perineum was 
cleaned and draped.
For transrectal prostate biopsy, 10 mls of 2% plain xylocaine 
was infiltrated in the periprostatic tissue at 3, 4, 8, 9 and 
12 O’clock positions using size 21G hypodermic needle. 
With the aid of a spring loaded disposable 18G biopsy 
needle, eight core tissue were taken guided by a finger in 
the rectum. For the transperineal prostate biopsy, 15 ml 
of 2% plain xylocaine was infiltrated into the perineum 
adjacent to the prostate including the periprostatic tissue 
using a 21G hypodermic needle. With the aid of a spring 
loaded disposable 18G biopsy needle, eight core tissues 
were taken through the perineum, guided by a finger in 
the rectum.
Immediately after the biopsy, the patient quantifies his 
pains with the aid of the VAS. He is later discharged home 
on a 5 day course of oral ciprofloxacin 500 mg bd and tabs 
metronidazole 400 mg tds. The patient visits the clinic on 
the 7th and 30th day after the procedure where a validated 
purpose designed questionnaire is administered to measure 
complications associated with the procedure. Tissue yield is 
measured by histology report confirming adequacy of tissue 
and reporting a histological diagnosis; while any bleeding per 
rectum that occurred after the procedure or within a month 
after the procedure was considered as post procedure rectal 
bleeding or rectal bleeding during the procedure resulting 
in haemodynamic changes.
The data generated in the study was analyzed by STATA; 
Level of significance was set at a two‑tailed P < 0.05. 
The data were tested for normality using Skewness and 
Kurtosis test; pnorm was used to test for normality of 
residuals. The VAS for both groups was tested by t‑test 
for a significant difference in mean; while the remaining 
variables were tested for a significant difference using the 
odds ratio (OR).
Results
Sixty‑five percent of the participants were farmers and 
uneducated, 13% of the participants who are civil servants 
were educated.
The mean age of the 75 patients recruited for the study 
was 64.01 ± 10.1 years. The mean VAS in the study 
is 7.178 ± 2.09. For TRbx, the mean VAS score was 
5.9 ± 1.5; while the mean VAS score for TPbx was 
8.02 ± 2.[Table 1] Subjecting these VAS scores to paired 
Student’s t‑test for a significant difference in mean, 
revealed a statistical significant difference between the two 
procedures (P < 0.0001;df: 75; t: 4.98; 95% confidence 
interval (CI) of difference in mean: −2.98−[−1.28])
Complications associated with prostatic biopsy are shown 
in Table 2. The risk of developing fever is not significantly 
different between the two groups, 13.6% for TPbx versus 
13.3% for TRbx (OR: 1.38; 95%CI: 0.32–6.02; P = 0.66). 
The risk of rectal bleeding was higher for transrectal 
prostate biopsy compared to transperineal prostate 
biopsy (OR: 0.03; 95%CI: 0.001–0.45; P = 0.012). The 
“number needed to treat” for TPbx to avoid rectal bleeding 
is 4 (RR: 2.98; 95%CI: 2.0–4.31; P < 0.001). With respect 
to the rest of the complications considered, there was 
no statistically significant difference between TRbx and 
TPbx [Table 2].
Table 1: The descriptive table of participants showing age and VAS
Route of biopsy
Variables Transrectal Transperineal
Observation Mean SD Minimum Maximum Observation Mean SD Minimum Maximum
Age 30 61.14 9.54 50 79 45 65.9 10.1 50 85
VAS 30 5.90 1.5 3 9 45 8.02 2.0 3 10
VAS=Visual analogue scale, SD=Standard deviation
Table 2: Multivariate analysis
Variables OR 95% CI for OR P value
Lower Upper
TPbx versus TRbx
Fever 1.38 0.32 6.02 0.664
Haemospermia 0.67 0.13 34.7 0.84
Rectal bleeding 0.03 0.001 0.45 0.012*
Prostatic abscess 0.67 0.013 34.7 0.84
Urethral bleeding 2.3 0.56 9.1 0.26
Blood transfusion 0.67 0.01 34.7 0.84
*P<0.05 statistically significant. CI=Confidence interval; OR=Odds ratio; 
TRbx=Transrectal prostate biopsy, TPbx=Transperineal prostate biopsy
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Discussion
The mean VAS >5 for transrectal biopsy in this study is 
similar to the observations made by Damiano et al.[19] in 
their study on TRUS guided prostate biopsy. Apparently, 
TPbx appears more painful than TRbx in the study. This 
finding is different from the observation of Hara et al.[20] in 
their study, whereby they concluded there was no significant 
difference in perception of pains. A closer look at their 
study showed they used spinal anesthesia for TPbx unlike 
in our study where a local infiltration of the perineum with 
periprostatic block was adopted. This implies that local 
infiltration of the perineum with periprostatic anaesthesia 
will not achieve sufficient anesthesia for TPbx. As such, 
unlike transrectal biopsy, it may be necessary to embrace 
other forms of anesthesia like pudendal block, caudal 
block or spinal anesthesia in order to achieve good pain 
control.[20,21] This opinion is not supported by some studies 
that found periprostatic block effective as well in TPbx.[7,22] 
The adequacy of periprostatic anaesthesia for TRbx was 
demonstrated by Maccagnano et al.[23] in their study using 
1 or 2% lidocaine (10 ml). They concluded that it was the 
most effective anesthetic technique for TRbx.
Additionally, most complications following prostate biopsy 
are minor and self‑limiting.[24] However, the rates of 
complications varied between the two methods of prostate 
biopsy in this study. With respect to post‑procedure pyrexia, 
its rate was higher for transperineal compared to transrectal. 
The OR of 1.38 implied an increased risk of fever in TPbx 
compared to TRbx. However, the observed difference lacked 
statistical significance as reflected in the P value and 95%CI, 
which has a value >1. The fever noted in the study were 
low grade in agreement with similar findings by Rietbergen 
et al.[25] The findings of 10.3% and 13.64% rates of fever 
following transrectal and TPbx is lower than the observed 
rate in the study done by Rosario et al.[26]
Moreover, urethral bleeding was more pronounced in TPbx 
than transrectal in this study though the difference lacked 
statistical significance. However, urethral bleeding is not 
usually associated with hemodynamic changes,[27] it could 
be a source of concern to patients and their relatives.
Furthermore, there was no case of rectal bleeding following 
TPbx in this study compared to TRbx in which 27.59% 
had rectal bleeding. This observed difference was proven 
to be statistically significant buttressing the fact that there 
is increased the risk of rectal bleeding via the transrectal 
route. This observation may be useful to the urologist when 
evaluating patients who have poorly controlled hypertension 
or obstructive nephropathy. Such patients usually have a 
higher risk of rectal bleeding and may benefit from TPbx. 
Rosario et al.[26] in their study noted that 36.8% of patients had 
rectal bleeding following prostate biopsy. This value exceeded 
that of TRbx in this study. Occasionally rectal bleeding could 
be massive necessitating blood transfusion and sometimes 
embolization.[28] In our series we experienced no case of 
massive rectal bleeding, which required blood transfusion.[29]
Surprisingly, there were no observed cases of hemospermia 
for both TRbx and TPbx. Though, in the literature, it is 
acknowledged that it is rare.[29] Our study participants are 
elderly and generally less sexually active which may account 
for the absence of any observed case of hemospermia. In 
addition, the caliber of the needle used (18G) may be 
contributory. Though, this has been refuted by Cicione 
et al.[30] who compared the outcomes of a 16G and 18G biopsy 
needle and found out no significant difference in outcome.
Generally, most studies that compared TRbx and 
TPbx concluded there was no significant difference in 
complication rates.[20,22,31] A systematic review by Shen 
et al.[15] also, revealed there was no significant difference 
in cancer detection between TRbx and TPbx irrespective 
of DRE findings or PSA level prior to biopsy. With respect 
to complications, there was no significant difference in the 
incidence of major or minor complications between the two 
groups. A limitation of this review is that a few randomized 
controlled studies were considered.
This result should be reproducible in ultrasound guided 
biopsies considering that some studies have shown no 
significant difference in outcomes between digital guided 
and ultrasound guided biopsies.[9,10,32]
This study is limited by its inability to make provisions for 
the losses to follow up; however, its findings should stimulate 
an elaborate multi centered randomized clinical trial to 
evaluate the differences in both procedures considering that 
there are very few published randomized studies available 
in the literature.
Conclusion
Transperineal prostate biopsy is more painful than transrectal 
prostate biopsy though with a significantly reduced risk 
of rectal bleeding. There appears to be no significant 
difference with respect to risk of fever, urethral bleeding, 
hematospermia, prostatic abscess and acute retention. Both 
routes provide sufficient prostate tissue for histology.
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